Solving the Insoluble: Webinar on the Science and Application of the Dispersome® Technology

Do you have problems with insoluble drugs or nutraceutical candidates? This new webinar highlights the use of beta-lactoglobulin as a novel excipient in Dispersome® formulations, a new solubility-enhancing technology that can improve performance and increase bioavailability.

Register Free: https://www.pharmtech.com/pt_w/solving-the-insoluble

Event Overview:

Poor drug solubility remains a big headache for biotech and pharma companies, resulting in severe delays or even drug development failure. Increasing drug solubility by applying the Dispersome® technology results in enhanced oral bioavailability, lower drug dosing, and better formulations. The Dispersome® technology is a new solubility-enhancing technology and is a compelling alternative to other solubility-enhancing technologies, simply because Dispersome® provide better performance with respect to solubility and bioavailability increase, even of practically insoluble drugs. The technology is based on the use of pharma-grade beta-lactoglobulin (BLG) as a novel pharmaceutical excipient, which stabilizes the drug into an amorphous and highly soluble form. This webinar will give a comprehensive overview on the science behind the Dispersome® technology and showcase different case studies for several programs in the pharmaceutical and neutraceutical space.

Key Learning Objectives

• Gain insights on the science behind solubility enhancement using the Dispersome® technology.
• Learn how the technology can be applied for developing more new drugs into commercial products and allows for improvement of existing drugs.
• Understand how the technology can be applied in the nutraceutical space.

Who Should Attend

• Pharmaceutical researchers and scientists
• Oral product development professionals
• CMC experts on oral drug delivery and formulation
• Business development, portfolio management, and technology licensing experts

Speakers
Korbinian Löbmann, PhD
Chief Scientific Officer
Zerion Pharma A/S

Emmanuel Heinrich, PhD
Fellow Scientist
Hovione

Register Free: https://www.pharmtech.com/pt_w/solving-the-insoluble